The businesses -- and investors -- behind the controversial Enhanced Games

Key Concepts

• Enhanced Games: A controversial, privately funded sports competition allowing the use of performance-enhancing drugs (PEDs) under medical supervision.
• Biohacking: The practice of using science and technology (including supplements and hormone therapy) to enhance human biological performance.
• Performance-Enhancing Drugs (PEDs): Substances used to improve athletic performance, currently banned by the World Anti-Doping Agency (WADA).
• Direct-to-Consumer (DTC) Model: A business strategy where companies sell products (supplements, telehealth services) directly to customers, bypassing traditional retail intermediaries.

---

The Business Model of the Enhanced Games

The Enhanced Games, scheduled for its inaugural event in Las Vegas on May 24, represents a shift from traditional sports governance to a profit-driven, commercialized model. While organizers frame the event as a pursuit of "transparency, science, and pushing human performance forward," the underlying structure is heavily focused on financial incentives and the biohacking industry.

Financial Incentives for Athletes

The primary draw for athletes is the significant disparity between traditional Olympic compensation and the Enhanced Games' prize structure:

• Prize Money: Each event offers a $500,000 purse, with $250,000 for the winner.
• Record-Breaking Bonuses: Athletes can earn seven-figure bonuses for breaking world records in specific events like the 100-meter sprint and 50-meter freestyle.
• Comparative Data: Olympic swimmer Ben Proud noted that an athlete would need to win world championship titles for 13 years to match the prize money offered for a single Enhanced Games race.
• Case Study (Kristian Gkolomeev): During a 2025 promotional time trial, Gkolomeev swam the 50-meter freestyle in 20.89 seconds. While not an official world record, he earned a $1 million bonus—a figure significantly higher than the estimated $200,000 he earned over a 14-year career spanning four Olympics.

Corporate Structure and Investment

The Enhanced Games is not merely a sporting event but a venture-backed enterprise with a valuation of $1.2 billion before its first official race.

• Key Investors: The project is backed by high-profile figures, including tech billionaire Peter Thiel, biotech billionaire Christian Angermayer, and Donald Trump Jr.
• Diversified Revenue Streams: The business model extends beyond ticket sales and broadcasting. It integrates a broader ecosystem of:
  • Telehealth services.
  • Performance supplements.
  • Testosterone therapy.
  • Direct-to-consumer performance products.

Ethical and Regulatory Perspectives

The project faces intense scrutiny from established sporting bodies:

• The WADA Stance: The World Anti-Doping Agency (WADA) characterizes the project as "dangerous and irresponsible," citing concerns over athlete health and the normalization of drug use in sports.
• The "Limits" Dilemma: The core philosophical and ethical question raised by the Enhanced Games is the regulation of human biology. If performance enhancement becomes a profitable, legalized industry, the traditional boundaries of "fair play" and biological limits are challenged, leaving the question of who—or what—determines the acceptable threshold for human modification.

Conclusion

The Enhanced Games represents a fundamental pivot in the sports industry, moving away from the amateur-centric or regulated professional models toward a commercialized, bio-tech-integrated framework. By offering life-changing financial rewards, the organizers are successfully attracting athletes who feel underserved by the current Olympic financial model. However, the long-term viability and ethical implications of this model remain a subject of significant debate, particularly regarding the health risks of legalized doping and the influence of private capital on the future of human performance.